Atlas Trials

Salmeterol/Fluticasone 50/500 mcg Inhalation Powder Via Capsair vs Seretide Diskus 500 mcg Inhalation Powder in Patients With COPD

Clinical trial NCT03363503 · TERMINATED

Trial details

NCT number
NCT03363503
Sponsor
Neutec Ar-Ge San ve Tic A.Ş
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
COPD
Start date
2018-04-13
Primary completion
2022-04-13
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.